The cream introduced by Galderma, whose path-breaking products are
the preferred choice world over, is very effective for providing relief from stubborn dark patches and unevenness that surface due to various hyperpigmentary disorders.
The company has roped in dazzling Bollywood star and model Hazel Keech as its brand ambassador. The product contains natural skin lightening ingredients, along with UVB filter and anti-oxidants which act synergistically to block melanin hypersynthesis pathways and distribution, at various stages.
As per latest reports from IMS, India’s hyperpigmentation market is valued to be Rs. 391 crores and is growing at 19% per year. With its flagship brand Cetaphil, Galderma is present in the Indian market with its prescription-based products. Its aesthetic range of Restylane products, especially skin boosters, have been drawing encouraging response in the country.
“In India, people generally suffer from various hyperpigmentary disorders such as melasma and post-inflammatory hyperpigmentation (PIH) that result in an uneven skin tone. We are present in the Indian market for the last 15 years and have been introducing products which are unique and reliable. Like all our dermatology solutions, we are confident that our latest product will emerge as an effective dermatological solution for patients suffering from hyperpigmentary disorders and restore their skin with an even tone and glow,” says Mr G Sathya Narayanan, Managing Director, Galderma India.
BI-LUMA offers a unique, three-way solution – it corrects melanin hyper-synthesis and distribution; boosts anti-oxidant and anti-inflammatory defense; and protects the skin from UVB radiation.
BI-LUMA is available at chemist and drug stores across India. The usage of BI-LUMA cream is simple and is advised to be applied twice daily. The product spreads easily on the skin and shows visible results within four weeks.
About Galderma
Galderma is a global company founded in 1981 committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 34 wholly-owned affiliates with a worldwide network of distributors and more than 5,000 employees. Galderma’s extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence. With approximately 19% of revenues invested each year to discover and develop new products and access innovative technologies, the company is one of the world’s leading investors in dermatology R&D. Five state-of-the-art R&D centers and five manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.
Price : INR 360/-
Availability : BI-LUMA is available at chemist and drug stores across India
No comments:
Post a Comment